Torsten Malmström
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Torsten Malmström formerly worked at Zealand Pharma A, as Director-Pharmaceutical Development, PolyPeptide Laboratories (Sweden) AB, as Development Director, AstraZeneca AB, as Team Manager, and Camurus AB, as Vice President-Technical Operations.
Dr. Malmström received his doctorate degree from the University of Lund.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CAMURUS AB 0,06% | 31-12-2024 | 35.363 ( 0,06% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Corporate Officer/Principal | - |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology Manufactures polypeptide, custom peptide synthesis, peptide synthesis and generic peptides | Corporate Officer/Principal | - |
| ZEALAND PHARMA A/S | Corporate Officer/Principal | - |
| CAMURUS AB | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Camurus AB
Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PolyPeptide Laboratories (Sweden) AB
PolyPeptide Laboratories (Sweden) AB BiotechnologyHealth Technology Manufactures polypeptide, custom peptide synthesis, peptide synthesis and generic peptides | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau